Robust Growth of Pharmaceutical Industry in Bangladesh
The emerging health care need and challenges in South Asia have led to the robust growth of pharmaceutical products in the market. With this, leading companies from India, Bangladesh, and Sri Lanka are gearing up to make the best use of the opportunity. Bangladesh is one of the leading exporters of active pharmaceutical ingredients (API) and generic pharma products in South Asia. With the current industry growth rate, experts forecast that the industry will grow to over $5.5 billion by 2022. With some of the industry leading players such as Square, Beximco, and Incepta in the market, the country is expected to witness much growth in GDP revenue through the export operations of these companies. One of the fastest growing manufacturers of generic pharmaceutical products in Bangladesh, Beximco Pharmaceuticals Limited, has been a forerunner in many aspects of the industry’s developments. The recent developments in exports such as the supply of Carvedilol and Olopatadine, not only t...